The Board of Shanghai Junshi Biosciences Co., Ltd. announced the appointment of Dr. Meng Anming (Dr. Meng) as an independent non-executive Director was approved at the 2022 annual general meeting of the Company (AGM) held on 30 June 2023. The appointment of Dr. Meng as an independent non-executive Director has become effective on the date of the AGM, being 30 June 2023. As disclosed in the Previous Announcement, Dr. Chen Lieping (Dr. Chen) has resigned as an independent non-executive Director and a member of the Strategic Committee.

Dr. Chen's resignation has become effective upon the date of appointment of Dr. Meng as an independent non-executive Director, being 30 June 2023. Dr. Chen has confirmed that he has no disagreement with the Board, and there are no other matters that should be brought to the attention of the Shareholders in relation to his resignation. The Board announced that, following the resolution regarding the appointment of Dr. Meng as an independent non-executive Director being passed at the AGM and the resignation of Dr. Chen as an independent non-executive Director, with effect from 30 June 2023, Dr. Meng will be appointed as a member of the Strategic Committee and Dr. Chen will cease to be a member of the Strategic Committee.

Following the above change, the Strategic Committee will comprise three independent non-executive Directors, namely Dr. Roy Steven Herbst, Mr. Zhang Chun, and Dr. Meng Anming, and two executive Directors, namely Mr. Xiong Jun (chairman of the Strategic Committee) and Dr. Li Ning.